Datasets:

---

jason137

/

edgar_100

like 0

"Item 1.Business\nOverview\nOur mission is to give people the power to build community and bring the(...TRUNCATED)

"Item 1A.Risk Factors\nCertain factors may have a material adverse effect on our business, financial(...TRUNCATED)

"Item 2.Properties\nOur corporate headquarters are located in Menlo Park, California. As of December(...TRUNCATED)

"Item 3.Legal Proceedings\nBeginning on March 20, 2018, multiple putative class actions and derivati(...TRUNCATED)

"Item 5.Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of E(...TRUNCATED)

"Item 7.Management's Discussion and Analysis of Financial Condition and Results of Operations\nYou s(...TRUNCATED)

"Item 7A.Quantitative and Qualitative Disclosures About Market Risk\nWe are exposed to market risks,(...TRUNCATED)

"Item 8.Financial Statements and Supplementary Data\nMETA PLATFORMS, INC.\nINDEX TO CONSOLIDATED FIN(...TRUNCATED)

"Item 9A.Controls and Procedures\nEvaluation of Disclosure Controls and Procedures\nOur management, (...TRUNCATED)

"Item 9B.Other Information\nNone.\nItem 9C.Disclosure Regarding Foreign Jurisdictions that Prevent I(...TRUNCATED)

"Item 10.Directors, Executive Officers and Corporate Governance\nThe information required by this it(...TRUNCATED)

"Item 11.Executive Compensation\nThe information required by this item is incorporated by reference (...TRUNCATED)

"Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matt(...TRUNCATED)

"Item 13.Certain Relationships and Related Transactions, and Director Independence\nThe information (...TRUNCATED)

"Item 14.Principal Accountant Fees and Services\nThe information required by this item is incorporat(...TRUNCATED)

"Item 15. Exhibit and Financial Statement Schedules\nWe have filed the following documents as part o(...TRUNCATED)

"ITEM 1. BUSINESS.\nStryker Corporation (Stryker or the Company) is one of the world's leading medic(...TRUNCATED)

"ITEM 1A. RISK FACTORS.\nThis report contains statements that are not historical facts and are consi(...TRUNCATED)

"ITEM 2. PROPERTIES.\nWe have approximately 28 company-owned and 328 leased locations worldwide incl(...TRUNCATED)

"ITEM 3. LEGAL PROCEEDINGS.\nWe are involved in various proceedings, legal actions and claims arisin(...TRUNCATED)

"ITEM 5. MARKET FOR THE REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHAS(...TRUNCATED)

"ITEM 6. SELECTED FINANCIAL DATA.\nDollar amounts in millions except per share amounts or as otherwi(...TRUNCATED)

"ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.\nA(...TRUNCATED)

"ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.\nWe sell our products globally(...TRUNCATED)

"ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.\nREPORT OF INDEPENDENT REGISTERED PUBLIC ACCOU(...TRUNCATED)

"ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.\nNot (...TRUNCATED)

"ITEM 9A. CONTROLS AND PROCEDURES.\nEvaluation of Disclosure Controls and Procedures\nThe Company's (...TRUNCATED)

"ITEM 9B. OTHER INFORMATION.\nNot applicable.\nITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS T(...TRUNCATED)

"ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.\nInformation regarding our executi(...TRUNCATED)

"ITEM 11. EXECUTIVE COMPENSATION.\nInformation regarding the compensation of our management appearin(...TRUNCATED)

"ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MAT(...TRUNCATED)

"ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.\nThe informatio(...TRUNCATED)

"ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.\nThe information under the caption \"Proposal 2-Ra(...TRUNCATED)

"ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES.\nFORM 10-K-ITEM 15(a) 3. AND ITEM 15(c)\nSTRYKER (...TRUNCATED)

"Item 1.BUSINESS\nGeneral\nJohnson & Johnson and its subsidiaries (the Company) have approximately 1(...TRUNCATED)

"Item 1A. RISK FACTORS\nAn investment in the Company’s common stock or debt securities involves ri(...TRUNCATED)

"Item 2.PROPERTIES\nThe Company's subsidiaries operate 85 manufacturing facilities occupying approxi(...TRUNCATED)

"Item 3.LEGAL PROCEEDINGS\nThe information called for by this item is incorporated herein by referen(...TRUNCATED)

"Item 4.MINE SAFETY DISCLOSURES\nNot applicable.\nEXECUTIVE OFFICERS OF THE REGISTRANT\nListed below(...TRUNCATED)

"Item 5.MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF(...TRUNCATED)

"Item 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION\nOrg(...TRUNCATED)

"Item 7A.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK\nThe information called for by t(...TRUNCATED)

"Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA\nIndex to Audited Consolidated Financial Statem(...TRUNCATED)

"Item 9.CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE\nNot ap(...TRUNCATED)

"Item 9A.CONTROLS AND PROCEDURES\nDisclosure Controls and Procedures. At the end of the period cover(...TRUNCATED)

"Item 9B.OTHER INFORMATION\nNot applicable.\nItem 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THA(...TRUNCATED)

"Item 10.DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE\nThe information called for by this (...TRUNCATED)

"Item 11.EXECUTIVE COMPENSATION\nThe information called for by this item is incorporated herein by r(...TRUNCATED)

"Item 12.SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATT(...TRUNCATED)

"Item 13.CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE\nThe information (...TRUNCATED)

"Item 14.PRINCIPAL ACCOUNTANT FEES AND SERVICES\nThe information called for by this item is incorpor(...TRUNCATED)

"Item 15.EXHIBITS AND FINANCIAL STATEMENT SCHEDULES\nThe following documents are filed as part of th(...TRUNCATED)

"Item 1. BUSINESS.\nGeneral\nBristol-Myers Squibb Company was incorporated under the laws of the Sta(...TRUNCATED)

"Item 1A. RISK FACTORS.\nAny of the risks and uncertainties described below could significantly and (...TRUNCATED)

"Item 2. PROPERTIES.\nOur principal executive offices are located at 430 East 29th Street, 14th Floo(...TRUNCATED)

"Item 3. LEGAL PROCEEDINGS.\nInformation pertaining to legal proceedings can be found in “Item 8. (...TRUNCATED)

"Item 5. MARKET FOR THE REGISTRANT’S COMMON STOCK AND OTHER STOCKHOLDER MATTERS.\nBristol Myers Sq(...TRUNCATED)

"Item 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.\nM(...TRUNCATED)

"Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.\nWe are exposed to market risk(...TRUNCATED)

"Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.\nBRISTOL-MYERS SQUIBB COMPANY\nCONSOLIDATED ST(...TRUNCATED)

"Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.\nNone(...TRUNCATED)

"Item 9A. CONTROLS AND PROCEDURES.\nEvaluation of Disclosure Controls and Procedures\nAs of December(...TRUNCATED)

"Item 9B. OTHER INFORMATION.\nNone.\nItem 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVEN(...TRUNCATED)

"Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.\n(a)Reference is made to our 2022 (...TRUNCATED)

"Item 11. EXECUTIVE COMPENSATION.\nReference is made to our 2022 Proxy Statement with respect to Exe(...TRUNCATED)

"Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MAT(...TRUNCATED)

"Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.\nReference is made to our 2022 Proxy State(...TRUNCATED)

"Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES.\nReference is made to our 2022 Proxy Statement wit(...TRUNCATED)

"Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULE.\n(a)\nPage\nNumber\n1 Consolidated Financial St(...TRUNCATED)

"Item 1.\nBusiness.\nGeneral Development of Business\nGeneral\nPhilip Morris International Inc. is a(...TRUNCATED)

"Item 1A. Risk Factors.\nThe following risk factors should be read carefully in connection with eval(...TRUNCATED)

"Item 2. Properties.\nWe own or lease various manufacturing, office and research and development fac(...TRUNCATED)

"Item 3.\nLegal Proceedings.\nThe information called for by this Item is incorporated herein by refe(...TRUNCATED)

"Item 5.\nMarket for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases (...TRUNCATED)

"Item 6. Selected Financial Data.\n(in millions of dollars, except per share data)\n(1) Excluding cu(...TRUNCATED)

"Item 7.\nManagement’s Discussion and Analysis of Financial Condition and Results of Operations.\n(...TRUNCATED)

"Item 7A.\nQuantitative and Qualitative Disclosures About Market Risk.\nThe information called for b(...TRUNCATED)

"Item 8.\nFinancial Statements and Supplementary Data.\nConsolidated Statements of Earnings\n(in mil(...TRUNCATED)

"Item 9.\nChanges in and Disagreements with Accountants on Accounting and Financial Disclosure.\nNon(...TRUNCATED)

"Item 9A.\nControls and Procedures.\nPMI carried out an evaluation, with the participation of PMI’(...TRUNCATED)

"Item 9B.\nOther Information.\nNone.\nPART III\nExcept for the information relating to the executive(...TRUNCATED)

"Item 10.\nDirectors, Executive Officers and Corporate Governance.\nInformation About Our Executive (...TRUNCATED)

"Item 11.\nExecutive Compensation.\nRefer to Compensation Discussion and Analysis and Compensation o(...TRUNCATED)

"Item 12.\nSecurity Ownership of Certain Beneficial Owners and Management and Related Stockholder Ma(...TRUNCATED)

"Item 13. Certain Relationships and Related Transactions, and Director Independence.\nRefer to Relat(...TRUNCATED)

"Item 14.\nPrincipal Accounting Fees and Services.\nRefer to Audit Committee Matters section of the (...TRUNCATED)

"Item 15.\nExhibits and Financial Statement Schedules.\n(a) Index to Consolidated Financial Statemen(...TRUNCATED)

"Item 1. Business\nHoneywell International Inc. (“Honeywell” or “the Company”) invents and c(...TRUNCATED)

"Item 1A. Risk Factors\nCautionary Statement About Forward-Looking Statements\nWe describe many of t(...TRUNCATED)

"Item 2. Properties\nWe have approximately 932 locations, of which 242 are manufacturing sites. Our (...TRUNCATED)

"Item 3. Legal Proceedings\nWe are subject to a number of lawsuits, investigations and claims (some (...TRUNCATED)

"Item 4. Mine Safety Disclosures\nOne of our wholly-owned subsidiaries has a placer claim for and op(...TRUNCATED)

"Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases o(...TRUNCATED)

"Item 6. Selected Financial Data\n(1)\n2018 and 2017 Net Income attributable to Honeywell and Earnin(...TRUNCATED)

"Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations\n(D(...TRUNCATED)

"Item 7A. Quantitative and Qualitative Disclosures About Market Risks\nInformation relating to marke(...TRUNCATED)

"Item 8. Financial Statements and Supplementary Data\nHONEYWELL INTERNATIONAL INC.\nCONSOLIDATED STA(...TRUNCATED)

"Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure\nNot A(...TRUNCATED)

"Item 9A. Controls and Procedures\nHoneywell management maintains disclosure controls and procedures(...TRUNCATED)

"Item 10. Directors and Executive Officers of the Registrant\nInformation relating to the Directors (...TRUNCATED)

"Item 11. Executive Compensation\nInformation relating to executive compensation is contained in the(...TRUNCATED)

"Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Mat(...TRUNCATED)

"Item 13. Certain Relationships and Related Transactions\nInformation relating to certain relationsh(...TRUNCATED)

"Item 14. Principal Accounting Fees and Services\nInformation relating to fees paid to and services (...TRUNCATED)

"Item 15. Exhibits and Financial Statement Schedules\nItem 16. Form 10-K Summary\nNone.\nEXHIBIT IND(...TRUNCATED)

"Item 1. Business\nSPDR®\nGold Trust (the “Trust”) is an investment trust, formed on November 1(...TRUNCATED)

"Item 1A. Risk Factors\nYou should consider carefully the risks described below before making an inv(...TRUNCATED)

"Item 5.\nMarket for Registrant\n’\ns Common Equity, Related Stockholder Matters and Issuer Purcha(...TRUNCATED)

"Item 7. Management\n’\ns Discussion and Analysis of Financial Condition and Results of Operations(...TRUNCATED)

"Item 7A. Quantitative and Qualitative Disclosures about Market Risk\nThe Trust Indenture does not a(...TRUNCATED)

"Item 8. Financial Statements and Supplementary Data\nSee Index to Financial Statements on page\nfor(...TRUNCATED)

"Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure\nThere(...TRUNCATED)

"Item 9A. Controls and Procedures\nConclusion Regarding the Effectiveness of Disclosure Controls and(...TRUNCATED)

"Item 9B. Other Information\nNot applicable.\nItem 9C. Disclosure Regarding Foreign Jurisdictions th(...TRUNCATED)

"Item 10. Directors, Executive Officers and Corporate Governance\nThe Trust does not have any direct(...TRUNCATED)

"Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Mat(...TRUNCATED)

"Item 14. Principal Accounting Fees and Services\nOur independent registered public accounting firm (...TRUNCATED)

"Item 15. Exhibits and Financial Statements Schedules\n1. Financial Statements\nSee Index to Financi(...TRUNCATED)

"ITEM 1. BUSINESS\nOur Company\nNVIDIA pioneered accelerated computing to help solve the most challe(...TRUNCATED)

"ITEM 1A. RISK FACTORS\nIn evaluating NVIDIA and our business, the following factors should be consi(...TRUNCATED)

"ITEM 2. PROPERTIES\nOur headquarters complex is located in Santa Clara, California. It includes ten(...TRUNCATED)

"ITEM 3. LEGAL PROCEEDINGS\nPlease see Note 13 of the Notes to the Consolidated Financial Statements(...TRUNCATED)

"ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES O(...TRUNCATED)

"ITEM 6. SELECTED FINANCIAL DATA\nNo longer required as we have adopted certain provisions within th(...TRUNCATED)

"ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS\nTh(...TRUNCATED)

"ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK\nInvestment and Interest Rate R(...TRUNCATED)

"ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA\nThe information required by this Item is set f(...TRUNCATED)

"ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE\nNone.(...TRUNCATED)

"ITEM 9A. CONTROLS AND PROCEDURES\nControls and Procedures\nDisclosure Controls and Procedures\nBase(...TRUNCATED)

"ITEM 9B. OTHER INFORMATION\nNone.\nPART III\nCertain information required by Part III is omitted fr(...TRUNCATED)

"ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE\nIdentification of Directors\nInfor(...TRUNCATED)

"ITEM 11. EXECUTIVE COMPENSATION\nInformation regarding our executive compensation required by this (...TRUNCATED)

"ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MAT(...TRUNCATED)

"ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE\nInformation reg(...TRUNCATED)

"ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES\nInformation regarding accounting fees and services(...TRUNCATED)

"ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULE\nPage\n(a)\n1. Financial Statements\nReport of Inde(...TRUNCATED)

"Item 1. BUSINESS\nAmgen Inc. (including its subsidiaries, referred to as “Amgen,” “the Compan(...TRUNCATED)

"Item 1A. RISK FACTORS\nThis report and other documents we file with the SEC contain forward-looking(...TRUNCATED)

"Item 2. PROPERTIES\nAs of December 31, 2020, we owned or leased approximately 180 properties. The l(...TRUNCATED)

"Item 3. LEGAL PROCEEDINGS\nCertain of the legal proceedings in which we are involved are discussed (...TRUNCATED)

"Item 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES O(...TRUNCATED)

"Item 6. SELECTED FINANCIAL DATA\n(1) In 2017, we recorded a net charge of $6.1 billion as a result (...TRUNCATED)

"Item 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS\nTh(...TRUNCATED)

"Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK\nWe are exposed to market risks(...TRUNCATED)

"Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA\nThe information required by this item is incor(...TRUNCATED)

"Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE\nNone.(...TRUNCATED)

"Item 9A. CONTROLS AND PROCEDURES\nWe maintain “disclosure controls and procedures,” as such ter(...TRUNCATED)

"Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE\nInformation about our Directors is(...TRUNCATED)

"Item 11. EXECUTIVE COMPENSATION\nInformation about director and executive compensation is incorpora(...TRUNCATED)

"Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MAT(...TRUNCATED)

"Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE\nInformation abou(...TRUNCATED)

"Item 14. PRINCIPAL ACCOUNTING FEES AND SERVICES\nInformation about the fees for professional servic(...TRUNCATED)

"Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES\n(a)1.Index to Financial Statements\nThe following(...TRUNCATED)

"Item 1. Business\nMedtronic plc, headquartered in Dublin, Ireland, is among the world's largest med(...TRUNCATED)

"Item 1A. Risk Factors\nInvesting in our securities involves a variety of risks and uncertainties, k(...TRUNCATED)

"Item 2. Properties\nMedtronic's principal executive office is located in Ireland and is leased by t(...TRUNCATED)

"Item 3. Legal Proceedings\nA discussion of the Company’s legal proceedings is contained in Note 1(...TRUNCATED)

"Item 5. Market for Medtronic’s Common Equity, Related Shareholder Matters, and Issuer Purchases o(...TRUNCATED)

"Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations\nTh(...TRUNCATED)

"Item 7A. Quantitative and Qualitative Disclosures About Market Risk\nCURRENCY EXCHANGE RATE RISK\nD(...TRUNCATED)

"Item 8. Financial Statements and Supplementary Data\nReport of Independent Registered Public Accoun(...TRUNCATED)

"Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure\nNot a(...TRUNCATED)

"Item 9A. Controls and Procedures\nDisclosure Controls and Procedures\nOur management, with the part(...TRUNCATED)

"Item 9B. Other Information\nMedtronic has engaged in certain activities that it is required to disc(...TRUNCATED)

"Item 10. Directors, Executive Officers, and Corporate Governance\nThe sections entitled “Proposal(...TRUNCATED)

"Item 11. Executive Compensation\nThe sections entitled “Corporate Governance - Director Compensat(...TRUNCATED)

"Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Mat(...TRUNCATED)

"Item 13. Certain Relationships and Related Transactions, and Director Independence\nThe sections en(...TRUNCATED)

"Item 14. Principal Accounting Fees and Services\nThe sections entitled “Corporate Governance - Co(...TRUNCATED)

"Item 15. Exhibits and Financial Statement Schedules\n(a) 1. Financial Statement Schedules\nSchedule(...TRUNCATED)